Avantor, Inc. (AVTR)
After hours:
| Previous close | 22.82 |
| Open | 24.11 |
| Bid | 25.18 x 1400 |
| Ask | 25.49 x 1000 |
| Day's range | 24.00 - 25.86 |
| 52-week range | 16.63 - 26.16 |
| Volume | |
| Avg. volume | 8,149,459 |
| Market cap | 17.389B |
| Beta (5Y monthly) | 1.32 |
| PE ratio (TTM) | 67.37 |
| EPS (TTM) | 0.38 |
| Earnings date | 26 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.49 |
ZacksAvantor, Inc. (AVTR) Q2 Earnings and Revenues Beat Estimates
Avantor (AVTR) delivered earnings and revenue surprises of 8.70% and 0.01%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
PR NewswireAvantor® Reports Second Quarter 2024 Results
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its second fiscal quarter ended June 30, 2024."Our teams delivered another solid quarter with sequential improvements to all key financial metrics. Improved mix from increased bioprocessing revenue together with the accelerated impact of our cost transformation initiative drove more than 100 basi
PR NewswireAvantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:
